Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic & Testing Substances
- Sub-Industry: N/A
- Symbol: NASDAQ:LNTH
- CUSIP: N/A
- Web: investor.lantheus.com
- Market Cap: $704.27 million
- Outstanding Shares: 37,315,000
- 50 Day Moving Avg: $17.19
- 200 Day Moving Avg: $13.49
- 52 Week Range: $3.46 - $19.50
Sales & Book Value:
- Trailing P/E Ratio: 32.21
- Foreward P/E Ratio: 18.00
- P/E Growth: 1.32
- Annual Revenue: $306.74 million
- Price / Sales: 2.30
- Book Value: ($2.73) per share
- Price / Book: -6.92
- EBIDTA: $70.6 million
- Net Margins: 6.71%
- Return on Equity: -24.06%
- Return on Assets: 11.69%
- Debt-to-Equity Ratio: -2.63%
- Current Ratio: 2.73%
- Quick Ratio: 2.22%
- Average Volume: 826,343 shs.
- Beta: 0.93
- Short Ratio: 3.15
Frequently Asked Questions for Lantheus Holdings (NASDAQ:LNTH)
What is Lantheus Holdings' stock symbol?
Lantheus Holdings trades on the NASDAQ under the ticker symbol "LNTH."
How were Lantheus Holdings' earnings last quarter?
Lantheus Holdings, Inc. (NASDAQ:LNTH) released its earnings results on Tuesday, May, 2nd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.19 by $0.09. The company earned $81.36 million during the quarter, compared to analyst estimates of $77.75 million. Lantheus Holdings had a negative return on equity of 24.06% and a net margin of 6.71%. View Lantheus Holdings' Earnings History.
When will Lantheus Holdings make its next earnings announcement?
Where is Lantheus Holdings' stock going? Where will Lantheus Holdings' stock price be in 2017?
4 brokerages have issued 1 year price targets for Lantheus Holdings' shares. Their forecasts range from $9.00 to $22.00. On average, they expect Lantheus Holdings' stock price to reach $15.25 in the next twelve months. View Analyst Ratings for Lantheus Holdings.
Are investors shorting Lantheus Holdings?
Lantheus Holdings saw a decrease in short interest during the month of July. As of July 14th, there was short interest totalling 1,995,785 shares, a decrease of 28.1% from the June 30th total of 2,777,673 shares. Based on an average daily volume of 630,798 shares, the short-interest ratio is currently 3.2 days. Approximately 7.2% of the company's shares are short sold.
Who are some of Lantheus Holdings' key competitors?
Some companies that are related to Lantheus Holdings include Impax Laboratories (IPXL), CONMED Corporation (CNMD), Repligen Corporation (RGEN), USANA Health Sciences (USNA), Corcept Therapeutics Incorporated (CORT), Array BioPharma (ARRY), Foundation Medicine (FMI), Acceleron Pharma (XLRN), Quidel Corporation (QDEL), ABAXIS (ABAX), Global Blood Therapeutics (GBT), Dermira (DERM), Natus Medical Incorporated (BABY), Momenta Pharmaceuticals (MNTA), Medpace Holdings (MEDP), The Ensign Group (ENSG), Genomic Health (GHDX) and Xencor (XNCR).
Who are Lantheus Holdings' key executives?
Lantheus Holdings' management team includes the folowing people:
- Mary Anne Heino, President, Chief Executive Officer, Director
- John W. Crowley, Chief Financial Officer, Treasurer
- Michael P. Duffy, Senior Vice President, Strategy and Business Development, General Counsel and Secretary
- Timothy Healey, Senior Vice President, Commercial
- William C. Dawes JR, Vice President - Manufacturing and Operations
- Carol Walker, Vice President, Quality
- Simon Robinson, Vice President - Research & Pharmaceutical Development
- Cesare Orlandi M.D., Chief Medical Officer
- Brian A. Markison, Non-Executive Independent Chairman
- David F. Burgstahler, Director
When did Lantheus Holdings IPO?
(LNTH) raised $75 million in an IPO on Thursday, June 25th 2015. The company issued 7,900,000 shares at $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities served as the underwriters for the IPO and Baird was co-manager.
Who owns Lantheus Holdings stock?
Lantheus Holdings' stock is owned by a number of of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (3.33%), Boston Advisors LLC (0.95%), Russell Investments Group Ltd. (0.75%), Spark Investment Management LLC (0.70%), Capital One National Association (0.33%) and James Investment Research Inc. (0.24%). Company insiders that own Lantheus Holdings stock include Avista Capital Partners Gp, Ll, David F Burgstahler, Derace L Schaffer, Mary Anne Heino and Michael P Duffy. View Institutional Ownership Trends for Lantheus Holdings.
Who sold Lantheus Holdings stock? Who is selling Lantheus Holdings stock?
Lantheus Holdings' stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC and Spark Investment Management LLC. Company insiders that have sold Lantheus Holdings stock in the last year include Avista Capital Partners Gp, Ll, David F Burgstahler, Derace L Schaffer, Mary Anne Heino and Michael P Duffy. View Insider Buying and Selling for Lantheus Holdings.
Who bought Lantheus Holdings stock? Who is buying Lantheus Holdings stock?
Lantheus Holdings' stock was bought by a variety of institutional investors in the last quarter, including Boston Advisors LLC, Russell Investments Group Ltd., James Investment Research Inc., Capital One National Association, Eqis Capital Management Inc., Great West Life Assurance Co. Can, Capstone Asset Management Co. and Louisiana State Employees Retirement System. View Insider Buying and Selling for Lantheus Holdings.
How do I buy Lantheus Holdings stock?
Shares of Lantheus Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Lantheus Holdings' stock price today?
MarketBeat Community Rating for Lantheus Holdings (NASDAQ LNTH)MarketBeat's community ratings are surveys of what our community members think about Lantheus Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Lantheus Holdings stock can currently be purchased for approximately $18.90.
Consensus Ratings for Lantheus Holdings (NASDAQ:LNTH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating, 3 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.75)|
|Consensus Price Target: ||$15.25 (19.31% downside)|
Analysts' Ratings History for Lantheus Holdings (NASDAQ:LNTH)
(Data available from 7/27/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/17/2017||Cantor Fitzgerald||Initiated Coverage||Overweight||$22.00||High|
|6/30/2017||Jefferies Group LLC||Reiterated Rating||Buy||$18.00||Low|
|11/8/2016||Royal Bank Of Canada||Boost Price Target||Outperform||$6.00 -> $12.00||N/A|
|11/3/2016||Credit Suisse Group||Reiterated Rating||Hold||$9.00||N/A|
|4/11/2016||Robert W. Baird||Reiterated Rating||Hold||N/A|
|9/30/2015||Wells Fargo & Company||Downgrade||Outperform -> Market Perform||N/A|
Earnings History for Lantheus Holdings (NASDAQ:LNTH)Earnings History by Quarter for Lantheus Holdings (NASDAQ LNTH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017|| || || || || || || || |
|5/2/2017||Q1 2017||$0.19||$0.28||$77.75 million||$81.36 million||View||Listen|
|2/21/2017||Q416||$0.13||$0.18||$70.78 million||$74.35 million||View||Listen|
|8/4/2016||Q216||$0.06||$0.24||$72.66 million||$78.00 million||View||Listen|
|5/3/2016||Q116||$0.06||$0.15||$72.43 million||$76.50 million||View||Listen|
|2/22/2016||Q415||$0.02||$0.13||$71.47 million||$71.00 million||View||Listen|
|11/4/2015||Q315||$0.04||$0.18||$73.65 million||$74.10 million||View||Listen|
|8/4/2015||Q215||($0.14)||$0.05||$72.41 million||$73.30 million||View||Listen|
Earnings Estimates for Lantheus Holdings (NASDAQ:LNTH)
2017 EPS Consensus Estimate: $0.92
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Lantheus Holdings (NASDAQ:LNTH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Lantheus Holdings (NASDAQ:LNTH)
Insider Ownership Percentage: 2.30%Insider Trades by Quarter for Lantheus Holdings (NASDAQ:LNTH)
Institutional Ownership Percentage: 64.83%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|7/12/2017||Mary Anne Heino||CEO||Sell||10,000||$18.05||$180,500.00|| |
|6/20/2017||David F Burgstahler||Director||Sell||3,000,000||$14.87||$44,610,000.00|| |
|6/12/2017||Mary Anne Heino||CEO||Sell||10,000||$15.39||$153,900.00|| |
|6/12/2017||Michael P Duffy||Insider||Sell||20,000||$15.42||$308,400.00|| |
|5/10/2017||Derace L Schaffer||Director||Sell||10,000||$15.75||$157,500.00|| |
|5/9/2017||Avista Capital Partners Gp, Ll||Major Shareholder||Sell||3,000,000||$13.40||$40,200,000.00|| |
|5/9/2017||Derace L Schaffer||Director||Sell||10,000||$14.75||$147,500.00|| |
|3/17/2017||David F Burgstahler||Director||Sell||3,000,000||$12.20||$36,600,000.00|| |
|11/21/2016||David F Burgstahler||Director||Sell||2,500,000||$9.00||$22,500,000.00|| |
Headline Trends for Lantheus Holdings (NASDAQ:LNTH)
Latest Headlines for Lantheus Holdings (NASDAQ:LNTH)
|Lantheus Holdings, Inc. (LNTH) Expected to Post FY2017 Earnings of $0.94 Per Share|
www.americanbankingnews.com - July 20 at 10:00 AM
|Lantheus Holdings to Host Second Quarter 2017 Earnings Conference Call on August 1, 2017 at 4:30 p.m. Eastern Time|
finance.yahoo.com - July 18 at 4:47 PM
|Insider Selling: Lantheus Holdings, Inc. (LNTH) CEO Sells 10,000 Shares of Stock|
www.americanbankingnews.com - July 14 at 8:26 PM
|Zacks: Brokerages Anticipate Lantheus Holdings, Inc. (LNTH) Will Announce Quarterly Sales of $80.85 Million|
www.americanbankingnews.com - July 14 at 4:20 PM
|Lantheus Holdings, Inc. (NASDAQ:LNTH) Short Interest Up 371.6% in June|
www.americanbankingnews.com - July 14 at 7:34 AM
| Brokerages Anticipate Lantheus Holdings, Inc. (NASDAQ:LNTH) Will Post Earnings of $0.24 Per Share|
www.americanbankingnews.com - July 12 at 8:44 AM
|Analyzing Lantheus Holdings (LNTH) and Biocept (BIOC)|
www.americanbankingnews.com - July 10 at 7:47 AM
|Lantheus Holdings at 52-Week High: What's Driving the Stock?|
www.zacks.com - July 5 at 4:26 AM
|Lantheus Holdings' (LNTH) Buy Rating Reiterated at Jefferies Group LLC|
www.americanbankingnews.com - June 30 at 8:02 AM
|Lantheus Holdings, Inc. (LNTH) Short Interest Down 59.2% in June|
www.americanbankingnews.com - June 30 at 7:14 AM
|Head to Head Comparison: Lantheus Holdings (LNTH) vs. Quotient Limited (QTNT)|
www.americanbankingnews.com - June 27 at 7:48 AM
|Lantheus (LNTH) Scores a Strong Buy Right Now: Here's How|
finance.yahoo.com - June 23 at 7:45 AM
|Insider Selling: Lantheus Holdings, Inc. (LNTH) Director Sells 3,000,000 Shares of Stock|
www.americanbankingnews.com - June 22 at 10:26 PM
|Lantheus Holdings, Inc. (LNTH) Expected to Post Quarterly Sales of $80.85 Million|
www.americanbankingnews.com - June 18 at 10:48 AM
|Lantheus Holdings, Inc. (LNTH) Expected to Announce Earnings of $0.24 Per Share|
www.americanbankingnews.com - June 16 at 11:38 AM
|After-Hours Stock Movers 06/14: (APPS) (ROX) (LAKE) Higher; (PACB) (LNTH) (OAKS) Lower (more...)|
www.streetinsider.com - June 14 at 9:12 PM
|The Zacks Analyst Blog Highlights: Lantheus Holdings, Nutrisystem, Telecom Argentina, Chemours and British American Tobacco|
finance.yahoo.com - June 13 at 6:19 PM
|Short Interest in Lantheus Holdings, Inc. (LNTH) Grows By 159.4%|
www.americanbankingnews.com - June 13 at 7:08 AM
|Lantheus Holdings, Inc. (LNTH) CEO Sells $153,900.00 in Stock|
www.americanbankingnews.com - June 12 at 7:34 PM
|Insider Selling: Lantheus Holdings, Inc. (LNTH) Insider Sells 20,000 Shares of Stock|
www.americanbankingnews.com - June 12 at 7:34 PM
|Rotate Out of Tech: 5 Top Rated Picks from the Year's Leading Sectors|
finance.yahoo.com - June 12 at 3:37 PM
|5 Top Performing Efficient Stocks to Buy Now|
finance.yahoo.com - June 6 at 9:49 AM
|Lantheus Holdings, Inc. to Present at Jefferies 2017 Global Healthcare Conference|
finance.yahoo.com - May 23 at 5:53 PM
|ETFs with exposure to Lantheus Holdings, Inc. : May 22, 2017|
finance.yahoo.com - May 22 at 5:44 PM
|3 Reasons Why Lantheus Holdings (LNTH) is a Great Momentum Stock|
finance.yahoo.com - May 22 at 10:19 AM
|Zacks.com featured highlights: Baxter International, Lantheus Holdings, OraSure Technologies, MAM Software Group and Teradyne|
finance.yahoo.com - May 22 at 10:19 AM
|Insider Selling: Lantheus Holdings Inc (LNTH) Director Sells 10,000 Shares of Stock|
www.americanbankingnews.com - May 12 at 8:00 PM
|Lantheus Holdings Inc (LNTH) Major Shareholder Sells $40,200,000.00 in Stock|
www.americanbankingnews.com - May 11 at 7:22 PM
|ETFs with exposure to Lantheus Holdings, Inc. : May 9, 2017|
finance.yahoo.com - May 9 at 6:03 PM
|Lantheus Holdings, Inc. :LNTH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017|
finance.yahoo.com - May 8 at 5:55 PM
|Jefferies Group Equities Analysts Raise Earnings Estimates for Lantheus Holdings Inc (LNTH)|
www.americanbankingnews.com - May 5 at 7:58 PM
|Lantheus Holdings Inc (LNTH) Stock Rating Upgraded by Zacks Investment Research|
www.americanbankingnews.com - May 5 at 12:46 AM
|Research Analysts Offer Predictions for Lantheus Holdings Inc's Q2 2017 Earnings (LNTH)|
www.americanbankingnews.com - May 4 at 12:32 PM
|Lantheus Holdings Inc (LNTH) Expected to Post Earnings of $0.20 Per Share|
www.americanbankingnews.com - May 4 at 1:37 AM
|Lantheus Holdings Inc (LNTH) Expected to Post Quarterly Sales of $79.4 Million|
www.americanbankingnews.com - May 4 at 1:36 AM
|Edited Transcript of LNTH earnings conference call or presentation 2-May-17 8:30pm GMT|
finance.yahoo.com - May 4 at 12:35 AM
|Jefferies Group LLC Reiterates Buy Rating for Lantheus Holdings Inc (LNTH)|
www.americanbankingnews.com - May 3 at 10:56 PM
|Lantheus Holdings Inc (LNTH) Releases Earnings Results|
www.americanbankingnews.com - May 3 at 9:30 PM
|Why Lantheus Holdings Inc. Rocketed Today|
www.fool.com - May 3 at 1:19 PM
|Lantheus Holdings (LNTH) Earns Media Sentiment Rating of 0.16|
www.americanbankingnews.com - May 3 at 1:05 AM
|Lantheus Holdings posts 1Q profit|
marketbeat.com - May 2 at 6:13 PM
|Investor Network: Lantheus Holdings Inc. to Host Earnings Call|
finance.yahoo.com - May 2 at 4:22 PM
|Lantheus Holdings, Inc. Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance|
finance.yahoo.com - May 2 at 4:22 PM
|Lantheus Holdings Inc (LNTH) Expected to Post Quarterly Sales of $77.75 Million|
www.americanbankingnews.com - April 30 at 10:12 AM
|Lantheus Holdings (LNTH) Getting Somewhat Favorable Press Coverage, Study Shows|
www.americanbankingnews.com - April 29 at 7:42 PM
| Analysts Expect Lantheus Holdings Inc (LNTH) Will Announce Earnings of $0.19 Per Share|
www.americanbankingnews.com - April 28 at 8:55 AM
|Lantheus, GE Healthcare Sign License Deal For Flurpiridaz F 18 - Quick Facts|
www.rttnews.com - April 26 at 6:59 PM
|Lantheus Holdings (LNTH) Receiving Somewhat Positive Press Coverage, Study Finds|
www.americanbankingnews.com - April 26 at 6:38 PM
|Lantheus Holdings, Inc. breached its 50 day moving average in a Bearish Manner : LNTH-US : April 24, 2017|
finance.yahoo.com - April 24 at 2:40 PM
|Lantheus Holdings (LNTH) Earns Daily Media Sentiment Rating of 0.56|
www.americanbankingnews.com - April 20 at 11:57 AM
Lantheus Holdings (LNTH) Chart for Thursday, July, 27, 2017